Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
VE416 is an investigational live biotherapeutic product (LBP) taken orally developed by Vedanta Biosciences for the treatment of food allergies, with a primary focus on peanut allergy. It consists of a defined bacterial consortium produced from pure, clonal bacterial cell banks. This process ensures a uniform powdered drug product free of pathogenic strains, eliminating the need for inconsistent faecal donor material. In preclinical research, VE416 triggered protective immunoregulatory responses and reduced anaphylaxis and allergi…